Ajinomoto Animal Nutrition Europe

Ajinomoto Animal Nutrition Europe is a major bio-industry stakeholder in the circular economy through its production, recycling and environmental-friendly process. Ajinomoto belief is a strong environmental policy that guides all actions on a daily basis. Ajinomoto Animal Nutrition Europe produces amino acids using agricultural raw materials and natural fermentation processes. Involved in the circular economy, Ajinomoto innovations have multiple positive effects. Not only do they make it possible to ensure the best technical-economic performance, but they also reduce Europe’s protein dependency, greenhouse gas emissions and the environmental impact of livestock farming and meat production.

Illumina

Illumina, Inc. is an American company that develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets. Customers include genomic research centres, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Today’s agricultural researchers have many tools at their disposal for studying plant and animal genomics. Those who are interested in livestock biology know that an accurate view of the genetic influence on traits and disease is crucial. As genomics becomes more widely used in agriculture, researchers and breeders are increasingly using Illumina technology to drive discoveries and advances. Illumina supports the idea that microarray and next-generation sequencing (NGS) technologies are useful for studying various aspects of animal genomics, including genotype, gene expression and regulation, and epigenetics. These approaches offer the throughput, sensitivity, and precision needed to evaluate genetic markers and discover new ones associated with traits or disease.

Adisseo

Adisseo is a leading world-company in animal nutrition by improving food chain supporting the key actors in this field. Adisseo has a turnover of 1.46 billion euros in 2018 and over 3,900 customers. Adisseo had 3 business units, 15 plants, 10 research units, 2250 employees among which 175 are researchers. Adisseo mission is to feed the planet in a high-quality, affordable, safe and sustainable way. The vision of Adisseo is to feed the planet in a qualitative, affordable, safe, and sustainable ways. Adisseo contributes therefore to the sustainable growth of the planet by delivering innovative products and services to the feed and food industry.

Sponsoring Code of Practice

Relationships between the EAAP and its industrial supporters or any other potential partners should be based on equal partnership. Both sides must be prepared to move beyond a situation in which the EAAP is the passive recipient of money to one in which the two sides work together on policy development and on practical initiatives in the interests of all EAAP member organisations and individuals.

Each party should remember that successful partnerships are those where both partners gain by making the effort to understand the internal culture and external pressures of the other.
It is understood that industrial partners have to be profitable and have their own commercial agendas to which the EAAP is not obliged to conform. Funding will be declined if its application compromises the independence of the EAAP in any way.

The EAAP will use available funding so long as its independence is not compromised in any way, there is no conflict of interest and as long as the relationship with the funder is totally transparent. Contracts between the parties help in this respect.

The EAAP will not participate in relationships designed to give one company a competitive advantage over another and favours the funding consortia of two or more companies from the same or other industries.

The EAAP accepts funding from its industrial supporters and partners when:

  • it believes it will benefit the EAAP’s objectives
  • it is satisfied that accepting the funds will not include adverse publicity
  • the funder does not try to coerce or over‐influence EAAP policy either explicitly or implicitly
  • there is no conflict of interest or loss of independence

The EAAP’s name may not be used to imply approval or endorsement of any of the funder’s products.